Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
Downloadable CCO resource summarizing best practices for detection of RET gene alterations in lung and thyroid tumors
Downloadable CCO resource summarizing efficacy data for recently FDA-approved next-generation RET inhibitors in lung and thyroid cancers
Short downloadable CCO resource summarizing approved indications, dosing, and key safety data for the selective RET inhibitors pralsetinib and selpercatinib
Download slides reviewing the latest clinical data informing optimal treatment of patients with RET-altered NSCLC and thyroid cancer, from Clinical Care Options
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.